COVID-19 Vaccine: The Failure of the Pasteur Institute

Second-order Cindynics, conflictuality reduction and operational efficiency
By IFREI - Published 17 March 2021 22:38 GMT-0000
Reading time < 4 minutes

The announcement of the termination of the Pasteur Institute's main COVID-19 vaccine candidate dismayed the French. At first, it seemed relevant to attribute this failure to the endemic failings of France, a country frequently perceived as sclerosed by its cultural or systemic inability to encourage innovative initiatives and its poor access to project funding. The MEDEF thus evokes the case of two French talents who had to leave France to fulfill their projects abroad: Stéphane Bancel, the creator of Moderna, and Pascal Soriot, the CEO of AstraZeneca.

This article is available to members of the IFREI community. You can join or renew your membership via this registration page.